Search

Diagnostics for neglected tropical diseases

ISNTD d³ 2021 addresses the current gaps and collaboration opportunities across tropical diseases and diseases of poverty to accelerate drug discovery & development, vaccine R&D and uptake, and diagnostics and surveillance opportunities. This year, against the backdrop of the recently launched WHO NTD Roadmap and the shock of the COVID-19 pandemic, ISNTD d³ has focused on the shifts, gaps and future needs of drug discovery, treatments and diagnostics in the context of global health.

Essential diagnostics for neglected tropical diseases: from technology to access for disease elimination

Dr Francis Moussy (Secretary, SAGE IVD and Essential Diagnostics List, WHO)
Launch of the World Health Organization’s third Essential Diagnostics List

​Dr Dziedzom Komi de Souza (Senior Scientific Officer, NTD programme, FIND)
Access to visceral leishmaniasis diagnostics and impact towards attaining the elimination targets in Kenya – video of presentation

Dr Jessica Clark (University of Glasgow)
Reconciling egg- and antigen-based estimates of Schistosoma mansoni clearance and reinfection; a modelling study

Dr Pytsje Hoekstra (Leiden University Medical Center, the Netherlands)
Schistosoma eggs, circulating antigens or DNA? What do these different diagnostic markers reveal when monitoring praziquantel treatment in a clinical trial?

View full session, including Q&A